Alamar Biosciences, Inc. (ALMR)
NASDAQ: ALMR · Real-Time Price · USD
21.49
+0.55 (2.63%)
Jun 4, 2026, 4:00 PM EDT - Market closed
Alamar Biosciences Market Cap
Alamar Biosciences has a market cap or net worth of $1.49 billion as of June 5, 2026.
Market Cap
1.49B
Enterprise Value
1.53B
1-Year Change
n/a
Ranking
Category
Stock Price
$21.49
Market Cap Chart
Since the IPO on April 17, 2026, Alamar Biosciences's market cap has increased from $1.14B to $1.49B, an increase of 31.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 3, 2026 | 1.45B | 0.67% |
| Jun 2, 2026 | 1.44B | 1.41% |
| Jun 1, 2026 | 1.42B | 0.34% |
| May 29, 2026 | 1.42B | 3.44% |
| May 28, 2026 | 1.37B | 3.35% |
| May 27, 2026 | 1.33B | 0.16% |
| May 26, 2026 | 1.32B | -4.84% |
| May 22, 2026 | 1.39B | -8.82% |
| May 21, 2026 | 1.52B | 9.13% |
| May 20, 2026 | 1.40B | -1.71% |
| May 19, 2026 | 1.42B | -1.68% |
| May 18, 2026 | 1.45B | -3.16% |
| May 15, 2026 | 1.49B | -4.31% |
| May 14, 2026 | 1.56B | -2.17% |
| May 13, 2026 | 1.59B | 0.17% |
| May 12, 2026 | 1.59B | -3.81% |
| May 11, 2026 | 1.66B | -0.33% |
| May 8, 2026 | 1.66B | 2.90% |
| May 7, 2026 | 1.61B | -0.76% |
| May 6, 2026 | 1.63B | -0.25% |
| May 5, 2026 | 1.63B | 0.59% |
| May 4, 2026 | 1.62B | -7.94% |
| May 1, 2026 | 1.76B | 3.08% |
| Apr 30, 2026 | 1.71B | 2.29% |
| Apr 29, 2026 | 1.67B | -6.24% |
| Apr 28, 2026 | 1.78B | -2.17% |
| Apr 27, 2026 | 1.82B | 7.45% |
| Apr 24, 2026 | 1.69B | 2.35% |
| Apr 23, 2026 | 1.66B | - |
| Apr 22, 2026 | 1.66B | 4.48% |
| Apr 21, 2026 | 1.58B | 5.59% |
| Apr 20, 2026 | 1.50B | 32.21% |
| Apr 17, 2026 | 1.14B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Warby Parker | 3.08B |
| LeMaitre Vascular | 2.09B |
| DENTSPLY SIRONA | 1.97B |
| Pulse Biosciences | 1.68B |
| STAAR Surgical Company | 1.42B |
| Anbio Biotechnology | 1.41B |
| BioLife Solutions | 1.34B |
| AtriCure | 1.31B |